VA
VR Adviser Portfolio holdings
AUM
$1.33B
This Quarter Return
-12.6%
1 Year Return
+6.92%
3 Year Return
+862.77%
5 Year Return
+1,580.48%
10 Year Return
–
AUM
$508M
AUM Growth
+$508M
(-18%)
Cap. Flow
+$35.9M
Cap. Flow
% of AUM
7.07%
Top 10 Holdings %
Top 10 Hldgs %
74.09%
Holding
34
New
7
Increased
6
Reduced
5
Closed
7
Top Buys
| 1 |
Cogent Biosciences
COGT
|
$26.6M |
| 2 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$25.5M |
| 3 |
INZY
Inozyme Pharma
INZY
|
$12.9M |
| 4 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$12.5M |
| 5 |
GH Research
GHRS
|
$11.3M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$13.9M |
| 2 |
Athira Pharma
ATHA
|
$13.5M |
| 3 |
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
|
$12.2M |
| 4 |
Nuvalent
NUVL
|
$11.2M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
$8.22M |
Sector Composition
| 1 | Healthcare | 96.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TCDA
1
DELISTED
Tricida, Inc. Common Stock
TCDA
| $69M | 13.6% | 7,132,079 +2,637,228 | +59% | +$25.5M |
|
2
Aclaris Therapeutics
ACRS
$209M
| $63.7M | 12.55% | 4,563,962 | – | – |
|
3
Relmada Therapeutics
RLMD
$37.2M
| $43.1M | 8.49% | 2,270,072 | – | – |
|
4
Travere Therapeutics
TVTX
$1.56B
| $41.5M | 8.17% | 1,711,102 -283,895 | -14% | -$6.88M |
|
|
5
Cogent Biosciences
COGT
$1.69B
| $36.4M | 7.17% | 4,038,117 +2,949,300 | +271% | +$26.6M |
|
|
6
GH Research
GHRS
$837M
| $31.8M | 6.26% | 3,185,573 +1,134,513 | +55% | +$11.3M |
|
7
Instil Bio
TIL
$182M
| $27.7M | 5.46% | 5,997,657 -867,419 | -13% | -$4.01M |
|
8
Celldex Therapeutics
CLDX
$1.47B
| $23.3M | 4.59% | 865,116 | – | – |
|
9
Viridian Therapeutics
VRDN
$1.5B
| $21.4M | 4.22% | 1,852,919 | – | – |
|
10
VistaGen Therapeutics
VTGN
$102M
| $18.2M | 3.59% | 20,697,286 +4,650,000 | +29% | +$4.09M |
|
|
MRNS
11
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $15.3M | 3.01% | 3,156,803 | – | – |
|
|
WHWK
12
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $14.5M | 2.85% | 1,173,518 -355,884 | -23% | -$4.38M |
|
|
INZY
13
DELISTED
Inozyme Pharma
INZY
| $12.9M | 2.55% | +2,709,987 | New | +$12.9M |
|
|
AKUS
14
DELISTED
Akouos, Inc. Common Stock
AKUS
| $12.5M | 2.46% | +2,667,119 | New | +$12.5M |
|
|
LIAN
15
DELISTED
LianBio American Depositary Shares
LIAN
| $11.6M | 2.29% | 5,378,341 | – | – |
|
|
JBIO
16
Jade Biosciences, Inc. Common Stock
JBIO
$258M
| $9.23M | 1.82% | 590,408 +439,371 | +291% | +$6.87M |
|
17
Trevi Therapeutics
TRVI
$883M
| $8.57M | 1.69% | +3,050,022 | New | +$8.57M |
|
|
KDNY
18
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $8.56M | 1.69% | 489,618 -794,203 | -62% | -$13.9M |
|
19
Annexon
ANNX
$226M
| $7.27M | 1.43% | +1,928,477 | New | +$7.27M |
|
20
Savara
SVRA
$567M
| $6.26M | 1.23% | 4,117,530 +2,212,265 | +116% | +$3.36M |
|
21
Lyra Therapeutics
LYRA
$11.5M
| $5.22M | 1.03% | +924,170 | New | +$5.22M |
|
|
PRVB
22
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $4.48M | 0.88% | 1,118,653 | – | – |
|
23
Altimmune
ALT
$338M
| $4.32M | 0.85% | 369,306 -390,413 | -51% | -$4.57M |
|
|
ATYR
24
aTyr Pharma
ATYR
$527M
| $3.96M | 0.78% | 1,398,889 | – | – |
|
|
AFMD
25
DELISTED
Affimed
AFMD
| $3.96M | 0.78% | 1,428,571 | – | – |
|